| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitochondria | 8 | 2012 | 755 | 1.490 |
Why?
|
| Reactive Oxygen Species | 10 | 2016 | 527 | 1.310 |
Why?
|
| Glycolysis | 7 | 2018 | 173 | 1.110 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2016 | 175 | 1.010 |
Why?
|
| Tumor Suppressor Protein p53 | 6 | 2016 | 788 | 0.990 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2025 | 14 | 0.950 |
Why?
|
| Organic Anion Transporters | 1 | 2025 | 21 | 0.950 |
Why?
|
| Glutathione | 6 | 2016 | 198 | 0.940 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2025 | 40 | 0.930 |
Why?
|
| Thyroid Hormones | 1 | 2025 | 70 | 0.920 |
Why?
|
| Isothiocyanates | 3 | 2016 | 13 | 0.920 |
Why?
|
| Antineoplastic Agents | 9 | 2023 | 1849 | 0.890 |
Why?
|
| Neoplasms | 11 | 2023 | 2984 | 0.850 |
Why?
|
| Stromal Cells | 3 | 2013 | 314 | 0.730 |
Why?
|
| Pancreatic Neoplasms | 6 | 2024 | 739 | 0.600 |
Why?
|
| Oxidation-Reduction | 6 | 2014 | 464 | 0.590 |
Why?
|
| Cell Survival | 8 | 2012 | 883 | 0.540 |
Why?
|
| Organelle Biogenesis | 1 | 2016 | 19 | 0.520 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 664 | 0.510 |
Why?
|
| Cell Communication | 2 | 2012 | 190 | 0.410 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2023 | 829 | 0.410 |
Why?
|
| Apoptosis | 8 | 2013 | 1928 | 0.410 |
Why?
|
| Brain | 1 | 2025 | 3223 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2014 | 637 | 0.380 |
Why?
|
| Cystine | 1 | 2012 | 17 | 0.380 |
Why?
|
| Mutation | 7 | 2025 | 6340 | 0.370 |
Why?
|
| NADPH Oxidases | 1 | 2012 | 115 | 0.360 |
Why?
|
| DNA, Mitochondrial | 4 | 2009 | 243 | 0.360 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 269 | 0.330 |
Why?
|
| Glutamine | 1 | 2011 | 218 | 0.330 |
Why?
|
| Lignans | 1 | 2009 | 6 | 0.310 |
Why?
|
| Pyruvates | 1 | 2009 | 21 | 0.310 |
Why?
|
| Energy Metabolism | 3 | 2018 | 815 | 0.310 |
Why?
|
| Hexokinase | 1 | 2009 | 25 | 0.310 |
Why?
|
| Biphenyl Compounds | 1 | 2009 | 63 | 0.300 |
Why?
|
| HEK293 Cells | 3 | 2025 | 825 | 0.300 |
Why?
|
| Reactive Nitrogen Species | 1 | 2008 | 8 | 0.300 |
Why?
|
| Carcinogens | 2 | 2008 | 135 | 0.290 |
Why?
|
| Nitrosamines | 1 | 2008 | 16 | 0.290 |
Why?
|
| Leukemia | 1 | 2011 | 374 | 0.290 |
Why?
|
| Cell Respiration | 3 | 2016 | 25 | 0.290 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 232 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2024 | 169 | 0.280 |
Why?
|
| Radiation Tolerance | 1 | 2008 | 66 | 0.280 |
Why?
|
| Animals | 18 | 2025 | 36184 | 0.280 |
Why?
|
| Esophagus | 1 | 2009 | 218 | 0.270 |
Why?
|
| Epithelial Cells | 2 | 2009 | 932 | 0.260 |
Why?
|
| Bile Acids and Salts | 1 | 2009 | 257 | 0.260 |
Why?
|
| Chalcones | 1 | 2006 | 5 | 0.250 |
Why?
|
| Boron Compounds | 1 | 2006 | 34 | 0.250 |
Why?
|
| Proteasome Inhibitors | 1 | 2006 | 66 | 0.250 |
Why?
|
| Cell Line, Tumor | 10 | 2018 | 3794 | 0.250 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 177 | 0.240 |
Why?
|
| Triiodothyronine | 1 | 2025 | 73 | 0.230 |
Why?
|
| RNA, Small Interfering | 5 | 2012 | 719 | 0.230 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 94 | 0.230 |
Why?
|
| Thyroxine | 1 | 2025 | 75 | 0.230 |
Why?
|
| DNA Damage | 2 | 2005 | 517 | 0.230 |
Why?
|
| Signal Transduction | 5 | 2014 | 4915 | 0.230 |
Why?
|
| Symporters | 1 | 2025 | 78 | 0.230 |
Why?
|
| Humans | 31 | 2025 | 133181 | 0.230 |
Why?
|
| Biological Transport | 1 | 2025 | 367 | 0.220 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 386 | 0.220 |
Why?
|
| Muscular Atrophy | 1 | 2025 | 91 | 0.220 |
Why?
|
| Blood-Brain Barrier | 1 | 2025 | 157 | 0.220 |
Why?
|
| Muscle Hypotonia | 1 | 2025 | 200 | 0.220 |
Why?
|
| Genomic Instability | 1 | 2005 | 245 | 0.210 |
Why?
|
| Cryoelectron Microscopy | 1 | 2025 | 246 | 0.210 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2023 | 21 | 0.210 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2024 | 79 | 0.210 |
Why?
|
| Proteostasis | 1 | 2023 | 38 | 0.200 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2023 | 149 | 0.200 |
Why?
|
| Endoribonucleases | 1 | 2023 | 86 | 0.200 |
Why?
|
| Models, Molecular | 1 | 2025 | 1147 | 0.180 |
Why?
|
| Adenocarcinoma | 3 | 2014 | 1013 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 2 | 2012 | 126 | 0.180 |
Why?
|
| Lung Neoplasms | 2 | 2024 | 1558 | 0.180 |
Why?
|
| Mice | 11 | 2024 | 18928 | 0.170 |
Why?
|
| HL-60 Cells | 2 | 2011 | 35 | 0.170 |
Why?
|
| Enzyme Inhibitors | 1 | 2023 | 606 | 0.170 |
Why?
|
| Immunoblotting | 4 | 2016 | 316 | 0.160 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 180 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 2125 | 0.160 |
Why?
|
| Oncogenes | 2 | 2011 | 181 | 0.150 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2018 | 66 | 0.150 |
Why?
|
| Transfection | 3 | 2012 | 1095 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2012 | 814 | 0.140 |
Why?
|
| Neoplastic Stem Cells | 2 | 2011 | 351 | 0.140 |
Why?
|
| Boronic Acids | 3 | 2006 | 48 | 0.140 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 18 | 0.130 |
Why?
|
| Peroxiredoxins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 11 | 0.130 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2016 | 5 | 0.130 |
Why?
|
| Glutaminase | 1 | 2016 | 17 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2013 | 780 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 500 | 0.120 |
Why?
|
| Enzyme Activation | 3 | 2012 | 640 | 0.110 |
Why?
|
| Cell Line | 2 | 2012 | 2855 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2016 | 373 | 0.110 |
Why?
|
| Models, Biological | 2 | 2011 | 1530 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 2 | 2005 | 229 | 0.110 |
Why?
|
| Deoxycytidine | 1 | 2014 | 84 | 0.110 |
Why?
|
| Genes, ras | 1 | 2014 | 101 | 0.110 |
Why?
|
| Cell Death | 2 | 2018 | 248 | 0.110 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 118 | 0.110 |
Why?
|
| RNA, Long Noncoding | 1 | 2016 | 248 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2014 | 1013 | 0.100 |
Why?
|
| NADPH Oxidase 1 | 1 | 2012 | 2 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 2 | 2012 | 1097 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 167 | 0.100 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 25 | 0.090 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 33 | 0.090 |
Why?
|
| Tetracycline | 1 | 2012 | 73 | 0.090 |
Why?
|
| HCT116 Cells | 2 | 2016 | 63 | 0.090 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 85 | 0.090 |
Why?
|
| Vidarabine | 1 | 2012 | 80 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 713 | 0.090 |
Why?
|
| NADH Dehydrogenase | 1 | 2011 | 6 | 0.090 |
Why?
|
| Molecular Weight | 1 | 2012 | 384 | 0.090 |
Why?
|
| Buthionine Sulfoximine | 1 | 2011 | 28 | 0.090 |
Why?
|
| Electron Transport Complex I | 1 | 2011 | 33 | 0.090 |
Why?
|
| Genes, Neoplasm | 1 | 2012 | 90 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2012 | 245 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2012 | 1136 | 0.090 |
Why?
|
| Immunoprecipitation | 2 | 2016 | 206 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 361 | 0.090 |
Why?
|
| Cysteine | 1 | 2012 | 143 | 0.090 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2018 | 899 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 400 | 0.090 |
Why?
|
| Plasmids | 1 | 2012 | 529 | 0.090 |
Why?
|
| Melanoma | 1 | 2018 | 953 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 216 | 0.080 |
Why?
|
| Membrane Potentials | 1 | 2011 | 316 | 0.080 |
Why?
|
| Carcinoma | 1 | 2013 | 305 | 0.080 |
Why?
|
| Cyclophilins | 1 | 2009 | 20 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1770 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2009 | 165 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2013 | 889 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2013 | 467 | 0.070 |
Why?
|
| Pyrazines | 2 | 2005 | 73 | 0.070 |
Why?
|
| Ubiquitin | 2 | 2006 | 151 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2011 | 487 | 0.070 |
Why?
|
| Radiation, Ionizing | 1 | 2008 | 43 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2006 | 91 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3978 | 0.070 |
Why?
|
| Thioredoxins | 1 | 2008 | 26 | 0.070 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 311 | 0.070 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 257 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 106 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 285 | 0.070 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2006 | 28 | 0.060 |
Why?
|
| Tumor Microenvironment | 1 | 2011 | 699 | 0.060 |
Why?
|
| DNA Polymerase gamma | 1 | 2005 | 21 | 0.060 |
Why?
|
| eIF-2 Kinase | 1 | 2005 | 36 | 0.060 |
Why?
|
| Lymphoma | 1 | 2009 | 331 | 0.060 |
Why?
|
| Antioxidants | 1 | 2008 | 366 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2006 | 319 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2006 | 277 | 0.060 |
Why?
|
| Base Sequence | 1 | 2009 | 3153 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 656 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2242 | 0.050 |
Why?
|
| Piperidines | 1 | 2006 | 241 | 0.050 |
Why?
|
| Homeostasis | 1 | 2008 | 748 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 511 | 0.050 |
Why?
|
| Metalloendopeptidases | 1 | 2024 | 103 | 0.050 |
Why?
|
| Calcium | 2 | 2005 | 1104 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2751 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2006 | 260 | 0.050 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 136 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2014 | 246 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2005 | 1582 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2002 | 223 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2005 | 1730 | 0.050 |
Why?
|
| Amino Acid Transport System y+ | 1 | 2018 | 7 | 0.040 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2018 | 16 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2018 | 94 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2005 | 1351 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2002 | 702 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2018 | 53 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 186 | 0.030 |
Why?
|
| Comet Assay | 1 | 2016 | 7 | 0.030 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 46 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2016 | 868 | 0.030 |
Why?
|
| Oxidants | 1 | 2016 | 33 | 0.030 |
Why?
|
| Peroxidase | 1 | 2016 | 65 | 0.030 |
Why?
|
| Thapsigargin | 2 | 2005 | 23 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2014 | 2559 | 0.030 |
Why?
|
| Caspase Inhibitors | 2 | 2005 | 35 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 1340 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2024 | 2190 | 0.030 |
Why?
|
| Bortezomib | 2 | 2005 | 71 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 69 | 0.030 |
Why?
|
| Caspases | 2 | 2005 | 166 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 366 | 0.030 |
Why?
|
| Histones | 1 | 2018 | 572 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 5032 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 318 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 131 | 0.030 |
Why?
|
| Zebrafish | 1 | 2016 | 419 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 614 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2016 | 378 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 29 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2013 | 57 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 143 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 74 | 0.020 |
Why?
|
| RNA Interference | 1 | 2014 | 546 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 200 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 4823 | 0.020 |
Why?
|
| Chemokines | 1 | 2013 | 132 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3131 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 399 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 477 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2013 | 256 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2006 | 1706 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2014 | 741 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 500 | 0.020 |
Why?
|
| Alleles | 1 | 2016 | 1694 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1136 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2876 | 0.020 |
Why?
|
| Female | 4 | 2018 | 71395 | 0.020 |
Why?
|
| NAD | 1 | 2006 | 50 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 103 | 0.020 |
Why?
|
| Tunicamycin | 1 | 2005 | 8 | 0.020 |
Why?
|
| Transcription Factor CHOP | 1 | 2005 | 5 | 0.020 |
Why?
|
| Cycloheximide | 1 | 2005 | 46 | 0.020 |
Why?
|
| Caspases, Initiator | 1 | 2005 | 6 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2005 | 37 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2005 | 52 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2005 | 93 | 0.010 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 258 | 0.010 |
Why?
|
| Drug Interactions | 1 | 2005 | 259 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2005 | 174 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 348 | 0.010 |
Why?
|
| Heat-Shock Proteins | 1 | 2005 | 204 | 0.010 |
Why?
|
| Pancreas | 1 | 2005 | 231 | 0.010 |
Why?
|
| Cisplatin | 1 | 2005 | 285 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2005 | 384 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 1083 | 0.010 |
Why?
|
| Cyclin A | 1 | 2002 | 18 | 0.010 |
Why?
|
| Period Circadian Proteins | 1 | 2002 | 31 | 0.010 |
Why?
|
| ARNTL Transcription Factors | 1 | 2002 | 42 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 45 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 677 | 0.010 |
Why?
|
| Dimerization | 1 | 2002 | 153 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 269 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2002 | 106 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2002 | 119 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 7137 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2002 | 218 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 765 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2002 | 619 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 403 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 624 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9921 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2002 | 1420 | 0.010 |
Why?
|
| Male | 2 | 2018 | 65478 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2002 | 1151 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 21448 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 2575 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 28912 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 4574 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 2718 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 6541 | 0.010 |
Why?
|
| Adult | 1 | 2013 | 31616 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 3359 | 0.010 |
Why?
|